Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2016 / Jun / Pump Up the Volume
Research & Innovations Anterior Segment Cataract

Pump Up the Volume

Why do “open bag” IOLs reduce PCO?

By Mark Hillen 6/9/2016 1 min read

Share

Figure 1. Diagram of a closed (a) and open (b) capsular bag preparation from human donor lenses. Adapted from (1).

Many attempts have been made over the years to help reduce the occurrence of posterior capsule opacification (PCO) after cataract surgery. Lens epithelial cells (LECs) are the target: anything that inhibits their migration to (and proliferation on) the posterior capsule will help. Square-edged IOLs were a great step forward; they formed a physical barrier to LEC migration – but alas, given enough time, that barrier will be breached. Over the years, a number of approaches have been made, including capsular polishing, the bag-in-the-lens procedure, and leaving the capsular bag open. The latter seems to work… but people have always speculated why? 

The hypothesis is this: unlike standard IOLs where the capsular bag “shrinkwraps” around the IOL, if the bag is open, it’s subject to greater irrigation by the aqueous humor, which washes away (or at least dilutes) the cytokines that promote LEC migration and proliferation. Eldred et al. (1) decided to test that hypothesis using human lens cell and tissue culture experiments. Using donor eyes, with lenses hydrodissected out through a small capsulorhexis, the researchers created a “closed bag” preparation (see Figure 1a) that was placed in cell culture. To mimic the dilution of growth factors, they simply cultured the tissue preparation in different volumes of culture media (1.5 and 6 mL) and measured the proportion of the posterior capsule that was covered by cells. Volume mattered: after only 8 days of culture, posterior capsule cell cover was significantly lower in the 6 mL group than the 1.5 mL group. The experiment was repeated with an “open bag” preparation (see Figure 1b): posterior capsule cell cover was sparse in the 1.5 mL group, and non-existent in the 6.0 mL group, lending further credence to their hypothesis. 

But if cytokines are at play, which ones are they? The team analyzed the media collected from the closed bag preparations: 24 cytokines were detectable in both the 1.5 mL and 6 mL cultures, but only nine were significantly reduced in the 6 mL culture (above and beyond that of simple fourfold dilution from the 1.5 mL culture). These were IL-8, IL-15, IL-12(p70), MCP-1, MIP-1β, IL-1ra, IL-10, IP-10 and VEGF. There’s a human fetal lens epithelium cell line available, FHL 124, so the researchers’ next step was to assess the effect of each cytokine on the migration of FHL 124 cells. Ultimately, VEGF was identified as the likely culprit, as both the VEGFR-1 and -2 receptors are expressed in these cells, and their migration was significantly reduced when the VEGF-receptor antagonist, axitinib, was added to the culture medium. Further, axitinib reduced cell cover in their initial “closed bag” model – suggesting that VEGF is a survival or growth factor for human LECs. So it looks like we have an explanation for why open-bag IOL use is associated with lower PCO rates – and it raises the question of whether the application of perioperative VEGF inhibitors to the capsular bag (perhaps as an IOL coating) might be another way of keeping those pesky LECs at bay.

References

  1. JA Eldred et al, “Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target”, Sci Rep, 6, 24453 (2016). PMID: 27076230.

About the Author(s)

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

More Articles by Mark Hillen

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: